STERIS plc (STE)

IE — Healthcare Sector
Peers: OFIX  NUVA  GKOS  HSKA  BRKR  CNMD  ANIK  ITGR  ZIMV  SYK  BSX  SNN  LIVN  IRTC  PODD  PEN  MASI 

Automate Your Wheel Strategy on STE

With Tiblio's Option Bot, you can configure your own wheel strategy including STE - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol STE
  • Rev/Share 55.5546
  • Book/Share 67.3202
  • PB 3.6393
  • Debt/Equity 0.0189
  • CurrentRatio 1.9574
  • ROIC 0.072

 

  • MktCap 24071446000.0
  • FreeCF/Share 7.9402
  • PFCF 30.8485
  • PE 39.1724
  • Debt/Assets 0.0123
  • DivYield 0.0091
  • ROE 0.0946

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 1
  • DCF Score 4
  • P/B Score 2
  • D/E Score 4

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation STE Jefferies -- Hold -- $263 May 29, 2025

News

AST Business Growth & Strategic Acquisitions Support STERIS Stock
STE
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive

STE frequently engages in strategic acquisitions and joint ventures to optimize its portfolio of businesses.

Read More
image for news AST Business Growth & Strategic Acquisitions Support STERIS Stock
Is it the Right Time to Hold STERIS Stock in Your Portfolio?
STE
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive

STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment.

Read More
image for news Is it the Right Time to Hold STERIS Stock in Your Portfolio?
Deciphering Steris (STE) International Revenue Trends
STE
Published: May 19, 2025 by: Zacks Investment Research
Sentiment: Neutral

Examine Steris' (STE) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Read More
image for news Deciphering Steris (STE) International Revenue Trends
STERIS plc (STE) Q4 2025 Earnings Call Transcript
STE
Published: May 15, 2025 by: Seeking Alpha
Sentiment: Neutral

STERIS plc (NYSE:STE ) Q4 2025 Results Conference Call May 15, 2025 9:00 AM ET Company Participants Julie Winter - Investor Relations Mike Tokich - Senior Vice President and Chief Financial Officer Dan Carestio - President and Chief Executive Officer Conference Call Participants Dave Turkaly - Citizens Mike Matson - Needham & Company Patrick Wood - Morgan Stanley Mac Etoch - Stephens, Inc Michael Polark - Wolfe Research Jason Bednar - Piper Sandler Brett Fishbin - KeyBanc Operator Good morning, everyone, and welcome to the STERIS plc Fourth Quarter 2025 Conference Call. All participants will be in a listen-only mode.

Read More
image for news STERIS plc (STE) Q4 2025 Earnings Call Transcript
STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket
STE
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive

STERIS' fourth-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues.

Read More
image for news STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket
What Analyst Projections for Key Metrics Reveal About Steris (STE) Q4 Earnings
STE
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Neutral

Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Read More
image for news What Analyst Projections for Key Metrics Reveal About Steris (STE) Q4 Earnings
10 Undervalued Dividend Growth Stocks: May 2025
AMAT, ELV, EOG, FELE, IMO, INTU, LRCX, STE, TMO, UNH
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Positive

I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and another comparing each stock's forward dividend yield with its 5-year average dividend yield. To rank stocks, I do a quality assessment and sort candidates by quality scores, breaking ties with additional metrics.

Read More
image for news 10 Undervalued Dividend Growth Stocks: May 2025
Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates?
STE
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive

STERIS is expected to have experienced an increase in bioprocessing demand in the fourth quarter.

Read More
image for news Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates?
Steris (STE) Up 3% Since Last Earnings Report: Can It Continue?
STE
Published: March 07, 2025 by: Zacks Investment Research
Sentiment: Positive

Steris (STE) reported earnings 30 days ago. What's next for the stock?

Read More
image for news Steris (STE) Up 3% Since Last Earnings Report: Can It Continue?

About STERIS plc (STE)

  • IPO Date 1992-06-01
  • Website https://www.steris.com
  • Industry Medical - Devices
  • CEO Mr. Daniel A. Carestio
  • Employees 18000

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.